Metal Powder Works Limited (ASX:MPW) Reinstated to Quotation
Metal Powder Works Limited (ASX:MPW) trading suspension is lifted as the company complies with ASX Listing Rules.
Tag: Regulatory News & Compliance
InFocus Group Holdings Limited (ASX:IFG) Secures Additional Placement Commitments
InFocus Group Holdings Limited (ASX:IFG) secures AUD 172,125 in placement commitments, totaling $422,125 for working capital and client projects.
European Metals Holdings Limited (ASX:EMH) Declares Cinovec as Strategic Deposit
European Metals (ASX:EMH) announces the Cinovec mineral deposit as a Strategic Deposit, expediting project permitting and development.
PhosCo Ltd (ASX:PHO) Requests Trading Halt
PhosCo Ltd (ASX:PHO) has halted trading pending an upcoming announcement on an exploration permit and capital raising.
Blackstone Minerals (ASX:BSX) Announces Visible Gold Discovery and Merger with IDM
Blackstone Minerals (ASX:BSX) announces visible gold discovery at Mankayan Project and a strategic merger with IDM International to enhance growth prospects.
Nagambie Resources (ASX:NAG) Increases Working Capital Facility by $1 Million
Nagambie Resources (ASX:NAG) increases its flexible working capital facility by $1M to support drilling programs at Nagambie Mine.
Industrial Minerals Limited (ASX:IND) Addresses ASX Price Query
Industrial Minerals Limited (ASX:IND) responds to ASX’s query on recent trading activity, citing increased demand for High Purity Quartz and ongoing project developments.
Guzman y Gomez Limited (ASX:GYG) Responds to ASX Compliance Inquiry on Half-Year Earnings
Guzman y Gomez Limited (ASX:GYG) confirms its half-year earnings aligned with market expectations in response to ASX compliance inquiry.
Biotron Limited (ASX:BIT) Withdraws Share Purchase Plan and Launches Rights Issue
Biotron Limited (ASX:BIT) withdraws its Share Purchase Plan and announces a $750,000 Rights Issue with Mahe Capital to secure its financial position.
Imricor Medical Systems (ASX:IMR) Submits Second FDA PMA Module
Imricor Medical Systems (ASX:IMR) submits its second FDA PMA module, advancing regulatory progress and preparing for upcoming product launches.